Mark Murcko
Founder presso RELAY THERAPEUTICS, INC.
Patrimonio netto: 8 M $ in data 31/03/2024
Posizioni attive di Mark Murcko
Società | Posizione | Inizio | Fine |
---|---|---|---|
RELAY THERAPEUTICS, INC. | Director/Board Member | 01/07/2016 | - |
Founder | 04/05/2015 | - | |
Chief Tech/Sci/R&D Officer | 01/02/2016 | 01/01/2018 | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Director/Board Member | - | - |
Quentis Therapeutics, Inc.
Quentis Therapeutics, Inc. BiotechnologyHealth Technology Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY. | Director/Board Member | 02/10/2018 | - |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | Director/Board Member | 07/11/2014 | - |
Gordon Research Conferences | Director/Board Member | - | - |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Director/Board Member | 01/11/2018 | - |
Corporate Officer/Principal | 01/11/2018 | - | |
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | Director/Board Member | - | - |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Director/Board Member | - | - |
Biohybrid Solutions Holding, Inc.
Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Director/Board Member | - | - |
Storia della carriera di Mark Murcko
Precedenti posizioni note di Mark Murcko
Società | Posizione | Inizio | Fine |
---|---|---|---|
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
░░░ ░░░░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Mark Murcko
Yale University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 14 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 11 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Settori
Health Technology | 11 |
Commercial Services | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
SQZ BIOTECHNOLOGIES COMPANY | Health Technology |
SCHRÖDINGER, INC. | Technology Services |
RELAY THERAPEUTICS, INC. | Health Technology |
Aziende private | 9 |
---|---|
Octant, Inc.
Octant, Inc. Miscellaneous Commercial ServicesCommercial Services Octant, Inc. operates as a biotechnology company. The company was founded by Sri Kosuri and Ramsey Homsany and is headquartered in Emeryville, CA. | Commercial Services |
Gordon Research Conferences | |
Morphic Therapeutic, Inc.
Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Health Technology |
Quentis Therapeutics, Inc.
Quentis Therapeutics, Inc. BiotechnologyHealth Technology Quentis Therapeutics, Inc. operates as a biotechnology company. It develops therapeutics in the onco-immunology field. The company was founded by Juan R. cubillos-Ruiz and is headquartered in New York, NY. | Health Technology |
Dewpoint Therapeutics, Inc.
Dewpoint Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Dewpoint Therapeutics, Inc. develops drugs. The company is headquartered in Boston, MA. | Health Technology |
Quvium UK Ltd.
Quvium UK Ltd. Medical SpecialtiesHealth Technology Quvium UK Ltd. engages in a medical device company. It specializes in developing constant-use solutions for chronic and acute respiratory conditions. The company was founded by Steven Schmidt and Karen Travers in 2013 and is headquartered in Sandwich, KE. | Health Technology |
HIBio, Inc.
HIBio, Inc. BiotechnologyHealth Technology HIBio, Inc. is a clinical immunology company that leverages human genetic and immunological insights to deliver targeted therapies to patients with severe immune-mediated diseases. The company is based in South San Francisco, CA. HIBio is excited to work as part of a collaborative team. HIBio was founded by Tim Behrens and Travis Murdoch, with Travis Murdoch serving as the CEO since incorporation. | Health Technology |
Biohybrid Solutions Holding, Inc.
Biohybrid Solutions Holding, Inc. BiotechnologyHealth Technology Biohybrid Solutions Holding, Inc. is a company that focuses on delivering safe and effective biologic drugs to patients worldwide. The company has partnered with the US government on a $38m DTRA program, which includes the discovery, manufacturing, testing, and scale-up of nanoarmored™ drugs. The company is based in Sharpsburg, PA. The company's world-renowned scientists are spearheading innovations in protein therapeutics by solving a problem facing the pharmaceutical industry: how to create longer-lived, more effective medicine. The company has developed the immunocontrol ™ platform, which can be used for epitopetargeting ™ and epitopeaccentuation ™, allowing for the discovery of new drugs against secondary, silent epitopes. The company has also modified cancer-fighting mini-proteins to increase pharmacokinetics. Biohybrid Solutions Holding was founded in 2016 by Antonina Simakova, Alan Russell, and Krzysztof Matyjaszewski. Jean Pineault has been the CEO of the company since 2021. | Health Technology |
Human Immunology Biosciences, Inc.
Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Mark Murcko
- Esperienza